Fox Hill Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $425K | Sell |
6,160
-225
| -4% | -$15.5K | 0.22% | 76 |
|
|
2025
Q1 | $443K | Sell |
6,385
-5,325
| -45% | -$370K | 0.26% | 71 |
|
|
2024
Q4 | $1.01M | Sell |
11,710
-18,638
| -61% | -$1.6M | 0.57% | 51 |
|
|
2024
Q3 | $3.61M | Buy |
30,348
+1,910
| +7% | +$227K | 1.99% | 10 |
|
|
2024
Q2 | $4.06M | Buy |
28,438
+118
| +0.4% | +$16.8K | 2.48% | 8 |
|
|
2024
Q1 | $3.64M | Buy |
28,320
+15,525
| +121% | +$1.99M | 2.45% | 9 |
|
|
2023
Q4 | $1.32M | Buy |
+12,795
| New | +$1.32M | 1.02% | 29 |
|